Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Olympus (OLYMY) Price & Analysis

OLYMY Stock Chart & Stats

$11.06-$0.15(-1.31%)
At close: 4:00 PM EDT
$11$12$1328 Jul10 Aug24 Aug4 Sep16 Sep9 Oct
Day’s Range
$11.06 - $11.06
52-Week Range
$8.21 - $13.78
Previous Close
$11.21
Volume
70.50K
Average Volume (3M)
839
Market Cap
$12.17B
Enterprise Value
$12.29B
Total Cash (Recent Filing)
$151.18B
Total Debt (Recent Filing)
$316.79B
Price to Earnings (P/E)
24.5
Beta
0.35
Next Earnings
Nov 10, 2026
EPS Estimate
0.14
Next Dividend Ex-Date
N/A
Dividend Yield
1.41%

Bulls Say, Bears Say

Bulls Say

Strong Operating Margins

Olympus maintains strong gross and EBITDA margins, indicating meaningful profitability from its medical-device operations and installed-base model. These margins provide capacity to fund product development, services, and commercial investment while offering resilience if procedure volumes or hospital capital spending fluctuate.

Manageable Leverage

Manageable leverage and a sizable equity base support Olympus’s financial flexibility over the next several quarters. A relatively moderate debt burden can reduce balance-sheet pressure, preserve access to funding, and leave greater capacity for investment in medical-device platforms and lifecycle services.

Improved Free Cash Flow

The sharp TTM improvement in free cash flow strengthens Olympus’s ability to internally fund operations, innovation, and customer support. Although conversion is not complete, better cash generation gives the company more flexibility to manage capital needs without relying as heavily on external financing.

Bears Say

Modest Revenue Growth

Revenue growth remains modest, limiting the pace at which Olympus can expand its earnings base despite its established medical-device position. Slower top-line growth may constrain operating leverage and makes sustained margin execution and successful adoption of new solutions more important to future performance.

Uneven Cash-Flow Quality

Historical cash-flow inconsistency reduces the reliability of reported earnings as a guide to internally generated funds. Negative or weak annual free cash flow can reflect working-capital or capital-spending swings, making funding for innovation, equipment support, and other priorities less predictable.

Low And Volatile Net Margin

A relatively low TTM net margin and significant period-to-period volatility show that strong gross and EBITDA margins do not consistently translate into bottom-line earnings. This weakens earnings visibility and leaves results more exposed to changes in costs, investment levels, or other operating factors.

Olympus News

OLYMY FAQ

What was Olympus’s price range in the past 12 months?
Olympus lowest stock price was $8.21 and its highest was $13.78 in the past 12 months.
What is Olympus’s market cap?
Olympus’s market cap is $12.17B.
When is Olympus’s upcoming earnings report date?
Olympus’s upcoming earnings report date is Nov 10, 2026 which is in 9 days.
How were Olympus’s earnings last quarter?
Olympus released its earnings results on Aug 07, 2026. The company reported $0.112 earnings per share for the quarter, beating the consensus estimate of $0.054 by $0.058.
Is Olympus overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Olympus pay dividends?
Olympus pays a Annually dividend of $0.16 which represents an annual dividend yield of 1.41%. See more information on Olympus dividends here
What is Olympus’s EPS estimate?
Olympus’s EPS estimate is 0.14.
How many shares outstanding does Olympus have?
Olympus has 1,114,485,700 shares outstanding.
What happened to Olympus’s price movement after its last earnings report?
Olympus reported an EPS of $0.112 in its last earnings report, beating expectations of $0.054. Following the earnings report the stock price went up 2.003%.
Which hedge fund is a major shareholder of Olympus?
Currently, no hedge funds are holding shares in OLYMY
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology